Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

S032 - Soft Tissue Augmentation: The Nasolabial Fold and Beyond

Saturday, February 17; 1:00 PM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Select the appropriate filler product for the underlying anatomic defect(s).
  • Demonstrate the proper technique(s) for soft-tissue augmentation for facial and body areas, aside from the nasolabial fold.
  • Design an appropriate treatment paradigm to minimize adverse reactions.

Description

Faculty will present innovative approaches to soft tissue augmentation of the face and body, including the forehead, temples, brows, midface, tear trough, lips, lower face, hands, and chest. Videos will demonstrate best practice techniques to maximize outcomes and minimize adverse events. Advanced treatment pearls will be shared to enhance participants' existing techniques.

Disclosures

  • Aguilera, Shino Bay, DO: no financial relationships exist with commercial interests.
  • Almeida, Ada R. Trindade, MD: Allergan, Inc. – C(H); Merz Pharmaceuticals, LLC – A(H), SP(H); Sinclair Pharma, LLC – A(H), SP(H);
  • Bertucci, Vince, MD: Allergan, Inc – C(Fees); Allergan, Inc. – A(Fees), I(Fees), SP(H); Croma-Pharma GmbH Austria – A(NC); Galderma Canada, Inc – A(Fees), SP(H); Galderma Laboratories, L.P. – A(Fees); Galderma USA – I(Fees); La Roche-Posay Laboratorie Pharmaceutique – A(Fees), SP(Fees); Merz Aesthetics – A(Fees), C(Fees), I(Fees); Revance Therapeutics, Inc. – C(Fees), I(Fees), SP(Fees); TEOXANE Laboratories – A(OB); Valeant Pharmaceuticals International – C(Fees);
  • Braz, Andre, MD: Allergan, Inc – A(H), SP(H); Merz Pharmaceuticals, LLC – SP(Fees);
  • Cox, Sue Ellen, MD: Allergan, Inc. – A(H), I(OB); Bayer Pharmaceuticals – I(OB); Candesant Biomedical, Inc. – SH(ST); Cearna, Inc – A(SO); Croma-Pharma GmbH Austria – I(OB); Evolus, Inc. – I(OB); Galderma Laboratories, L.P. – I(H); Merz Aesthetics – SP(H); Neothetics – I(OB); Revance Therapeutics, Inc. – I(OB); TEOXANE Laboratories – I(OB); TruInject Medical Corporation – SH(ST); Valeant Pharmaceuticals North America LLC – C(H);
  • Glaser, Dee Anna, MD: Allergan, Inc. – I(Grants/Research Funding), O(H); Dermira – A(H), I(Grants/Research Funding); Galderma Laboratories, L.P. – A(H); Galderma Research & Development, LLC – I(Grants/Research Funding); Miramar Labs – C(H); Revance Therapeutics, Inc. – I(Grants/Research Funding); Unilever Home & Personal Care USA – A(H);
Schedule
Saturday, February 17
1:00 PM
Dr. Cox / Full Face Approach with Fillers
1:20 PM
Dr. Almeida / Filling the Upper Face
2:00 PM
Dr. Bertucci / Filling the Midface and tear trough
2:30 PM
Dr. Braz / Filling the Lower Face and Lips
3:10 PM
Dr. Aguilera / Using fillers for the neck, chest, hands and buttocks
3:45 PM
All faculty / Questions and Answer session
Event Details
  • Date
    Saturday, February 17
  • Time
    1:00 PM - 4:00 PM
  • Location
    Room 6C
  • CME Credits
    3.00
  • Type
    Restricted
Directors/Co-Directors
  • Dee Anna Glaser, MD, FAAD
Speakers
  • Ada R. Trindade Almeida, MD
  • Andre Braz, MD
  • Shino Bay Aguilera, DO, FAAD
  • Sue Ellen Cox, MD, FAAD
  • Vince Bertucci, MD, FAAD